Pharmedic Pharmaceutical Medicinal Share Price

Equities

PMC

VN000000PMC3

Pharmaceuticals

End-of-day quote HANOI S.E. 03:30:00 05/06/2024 am IST 5-day change 1st Jan Change
85,500 VND -1.16% Intraday chart for Pharmedic Pharmaceutical Medicinal +6.88% -0.70%

Financials

Sales 2022 47TCr 1.84Cr 155.09Cr Sales 2023 49TCr 1.89Cr 159.34Cr Capitalization 80TCr 3.13Cr 263.88Cr
Net income 2022 8.34TCr 32.53L 27Cr Net income 2023 8.36TCr 32.59L 27Cr EV / Sales 2022 1.06 x
Net cash position 2022 29TCr 1.14Cr 96Cr Net cash position 2023 26TCr 1.02Cr 86Cr EV / Sales 2023 1.12 x
P/E ratio 2022
13 x
P/E ratio 2023
13.2 x
Employees 534
Yield 2022
3.53%
Yield 2023
17.4%
Free-Float 55.83%
More Fundamentals * Assessed data
Dynamic Chart
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Saigon - Hanoi Securities Joint Stock Company acquired additional 5.9% minority stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company (HNX : PMC). CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
1 day-1.16%
1 week+6.88%
Current month-1.72%
1 month+6.88%
3 months+5.56%
6 months-4.89%
Current year-0.70%
More quotes
1 week
83 200.00
Extreme 83200
87 000.00
1 month
75 000.00
Extreme 75000
88 900.00
Current year
73 600.00
Extreme 73600
88 900.00
1 year
63 000.00
Extreme 63000
93 000.00
3 years
59 000.00
Extreme 59000
93 000.00
5 years
36 100.00
Extreme 36100
93 000.00
10 years
36 100.00
Extreme 36100
102 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 -
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 62 -
Members of the board TitleAgeSince
Chief Executive Officer 67 -
Corporate Officer/Principal 82 01/82/01
Director/Board Member 61 01/00/01
More insiders
Date Price Change Volume
05/24/05 85,500 -1.16% 3,236
03/24/03 86,500 -0.57% 1,153
31/24/31 87,000 +8.75% 2,211
30/24/30 80,000 0.00% 849
29/24/29 80,000 -4.88% 2,240

End-of-day quote HANOI S.E., June 05, 2024

More quotes
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
More about the company